Treatment of Community-Acquired Uncomplicated Urinary Tract Infection.
- Author:
Hyunjoo PAI
1
Author Information
1. Division of Infectious Diseases, Hanyang University Hospital, Seoul, Korea. paihj@hanyang.ac.kr
- Publication Type:Review
- Keywords:
Urinary tract infection;
Treatment;
Antibiotic resistance
- MeSH:
Anti-Bacterial Agents;
Bacterial Infections;
Cefotaxime;
Ciprofloxacin;
Cystitis;
Drug Resistance, Microbial;
Escherichia coli;
Female;
Humans;
Korea;
Pyelonephritis;
Trimethoprim, Sulfamethoxazole Drug Combination;
Urinary Tract;
Urinary Tract Infections
- From:Korean Journal of Medicine
2011;81(6):685-689
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Acute uncomplicated urinary tract infections (UTI), episodes of cystitis or pyelonephritis that occur in healthy non-pregnant women with no functional or anatomic abnormalities of the urinary tract, are among the most commonly encountered bacterial infections. Unfortunately, there has been a recent trend of increasing resistance to antibiotics among uropathogens in many countries including Korea. The resistance rates of Escherichia coli from acute uncomplicated UTI during 2009 to ciprofloxacin (CIP), trimethoprim-sulfamethoxazole (SXT) and cefotaxime were 84.1%, 67.2% and 95.4%, respectively. Resistance both to SXT and CIP was detected in 10.6% of the E. coli isolates. Therefore, it is difficult to recommend the antibiotics which would not worsen the resistance problem and would be effective for community-acquired uncomplicated UTI as well. Considering the high resistance of uropathogens in Korea, several academic societies made the guideline for UTI, which will be briefly reviewed in this manuscript.
